Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.

MLA

Huguet, Annabelle, MD, et al. “Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.” Pediatric Infectious Disease Journal, vol. 38, no. 10, Oct. 2019, pp. 1025–26. EBSCOhost, https://doi.org/10.1097/INF.0000000000002413.

APA

Huguet, A., MD, Ader, F. M., PhD, Ohlmann, C., MD, Collardeau-Frachon, S. M., PhD, & Gillet, Y. M., PhD. (2019). Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin. Pediatric Infectious Disease Journal, 38(10), 1025–1026. https://doi.org/10.1097/INF.0000000000002413

Chicago

Huguet, Annabelle, MD, Florence MD Ader PhD, Camille Ohlmann MD, Sophie MD Collardeau-Frachon PhD, and Yves MD Gillet PhD. 2019. “Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.” Pediatric Infectious Disease Journal 38 (10): 1025–26. doi:10.1097/INF.0000000000002413.